New Companies and Technologies Report
 

The New Companies and Technologies Report: Reports offer a global view of emerging companies and innovative technologies by providing summary profiles with links to expanded profiles in the Global Database.
Sample Listings of the NCTR
Scroll through: View sample report
Dermatology. Psoriasis, Phototherapy. Company uses proprietary UV-based technology to develop safe and cost-effective phototherapeutic treatments for skin conditions, including psoriasis. Operations financed to date via an initial $1.3 million angel-financing round, $0.8 million in SBIR research grants and $3.3 million in start-up financing. Company is currently seeking an additional $10 million in equity capital, which will be used to fund post-launch research and development endeavors and marketing and sales efforts. Founded: 2001. #11394
Cardiology, Surgery. Aortic Stenosis, Valve Repair. Company has developed an aortic valve bypass graft system, allowing surgeons to relieve stenosis of the valve and administer valve replacement therapy while the heart is still beating. This device is intended for patients unable to handle the rigors of traditional valve surgery or at increased risk of experiencing serious complications after use of a heart-lung machine. The company is currently conducting animal studies and is in discussion with investors to raise sufficient funds to support subsequent human studies, expected to commence in 2010. Founded: 2006. #11256
Drug Delivery, Neurology. Headaches, Chronic Pain. Company develops drug-device combinations intended to provide relief to individuals suffering from central nervous system disorders and chronic pain, including a subcutaneous sumatriptan delivery platform for the treatment of migraine and cluster headaches planned for launch in the second half of 2009. Closed an $18 million financing round in July 2008. Founded: 2006, Employees: 47. #11335
Imaging, Radiology, Urology. Prostate Cancer, Tumor Monitoring. Company has developed a four-dimensional localization system that gathers accurate and continuous information regarding tumor location in the prostate. The company's technology addresses two major issues in modern radiation oncology: errors in treatment set-up and tumor motion during treatment. As of May 2008, this system has been FDA-cleared for use in prostatectomy patients as well as in patients with intact prostates. Founded: 1999. #7163
Cardiology, Patient Monitoring. ECG. Company offers a FDA- and FCC-approved wireless ECG data communication system that frees patients from traditional leads, while improving clinical outcomes. The global market for wireless medical technologies is expected to reach $10 billion by 2011. It was awarded a multi-year contract with a reputable provider of supply chain systems, effective from February 1, 2009. Founded: 2000. #10981
Drug Delivery, Immunology. Molecular Biology. Company offers site-specific biological systems using proprietary biocompatible linker technology that selectively adheres to proteins, drugs, cells and biomaterial surfaces to direct biological pathways toward intended outcomes. It was awarded multiple SBIR grants totaling $3.6 million in September 2008, including two Phase II grants for developing products in the orthopedic and dental markets. Founded: 2003. #2018
Software Systems. EMR. Patient Education. Hospital Efficiency. Company offers a system comprised of integrated software suites designed to provide interactive and personalized inpatient care experiences through the convenience of an in-room television monitor. Automated prompts invite patients to learn more about their care at the appropriate times (i.e., treatment protocol, progress of condition, safety). It also streamlines day-to-day administrative processes, including revenue generation. More than two million individual patient accounts have been launched since its release in November 2008. Founded: 1999. #10983
Ophthalmology. Visual Aids. Company develops wearable display technology intended to address vision impairments not correctable by surgery or traditional eyeglasses. This technology can also enhance visual experiences for sports fans and concertgoers. The company is now focused on integrating the required optical components and electronics into a smaller, portable form factor. Commercial prototypes are expected in 2009. Founded: 2006, Employees: 7. #10995
Oncology. Genetic Mutational Analysis, Pathology. Company offers a high throughput molecular profile system that combines genetic mutational analysis with conventional pathology analysis, allowing pathologists to analyze the acquired mutational damage implicated in cancer progression and to differentiate among various stages and types of lesions. The market for cancer diagnostics will reach $7.4 billion by 2009 and is expected to increase as more cancer cases are diagnosed. The company closed a $3 million round of financing in May 2008. Founded: 2004, Employees: 50. #10381
Surgery, Orthopedics. Tissue Stimulating Biomaterials, Implants. Healionics Corporation develops products for long-term implants based on their proprietary biomaterial technology. Implantation of medical devices can often have different complications that include recognition of the implant as a foreign body by the immune system and poor tissue integration into the site of implantation. The company's biomaterial is a three-dimensional scaffold that contains a specific pore size that minimizes the identification of implants as a foreign body but still promotes integration at the implant site by fostering healing. The biomaterial can be made according to different specifications to meet the needs of different implants.
Regenerative Medicine, Surgery. Tissue bonding and sealing. Company provides a patented surgical tissue bonding and sealing platform that reconnects human soft tissue in a quick, airtight, leakproof and bloodless manner using high frequency bipolar energy. It is capable of sealing vessels as large as seven millimeters in diameter and withstanding a vessel burst pressure as high as seven times the normal systolic blood pressure. This technology received FDA 510(k) clearance and CE Mark approval in 2008. The company next plans to implement its U.S. sales representative recruitment plan and ramp up production for distribution. Founded: 2007. #11508
Surgery. Hospital Safety, RFID. Company offers potentially cost-effective radiofrequency identification (RFID) system for detecting and counting surgical sponges, ensuring complete removal of foreign bodies post-procedure with minimal handling of soiled materials. Accounting for retained sponges and instruments alone costs American healthcare institutions $1 billion annually. The system received FDA 510(k) clearance in June 2007 and was commercially launched in March 2008. Founded: 2004, Employees: 12. #10954
Subscribe and receive charter discounts and other benefits.

Affiliates
Partial list of Universities, Incubators and Economic Development Organizations
Delaware Technology Park, Inc.
Nucleus: Kentucky's Life Sciences and Innovation Center
The University Financing Foundation
University of Kentucky Coldstream Research Campus
BioHio Research Park, Ohio State University
University of Maryland
Piedmont Triad Research Park
Purdue Research Foundation
Smith Carter
University of Missouri- Missouri Research Park
University of Arizona Office of Economic Development
Science Center
University Research Park
Fitzsimons Redevelopment Authority
Forest City New East Baltimore Partnership
Biomedical Research Foundation of Northwest Louisiana
Georgia Institute of Technology
University Technology Park at IIT
South Dakota State University Innovation Campus
Center for Emerging Technologies
Gateway University Research Park
University of Georgia BioBusiness Center
University of Maryland BioPark
Emory University
University of North Texas Discovery Park
Memphis Bioworks Foundation
University of Arizona Office of Economic Development
Johns Hopkins Montgomery County
Illinois Institute of Technology
Halleland Health Consulting
Texas State University-San Marcos
Bilbao Technology Park
Thailand Science Park
Life Science Partner, inc.
Science and Technology Park of Sicily
Chernoff Thompson Architects
Saint Joseph's Translational Research Institute
Leo A Daly
McMaster Innovation Park
LISA Vienna Region
Buffalo Niagara Medical Campus
AMX Management, Inc.
Smith Carter
The Whiting-Turner Contracting Company
Murcia Science Park
Taylor English Duma LLP
InVenture Partner
Biotechnology Industry Organization (BIO)
 The University Financing Foundation
McKee Voorhees & Sease
Wexford Science & Technology, LLC
Brookwood Group
Georgia Research Alliance
Battelle
Bilbao Technology Park
Affiliated Engineers, Inc.
Eva Klein & Associates, Ltd.
Heidelberg Technology Park
Specialty Operations Solutions
Centers for Disease Control and Prevention
McKee Voorhees & Sease
Scottish Development International
Japan Aerospace Exploration Agency
University City Science Center
Purdue Research Foundation
PTS Granada
Greater Oklahoma City Chamber
U.S. Department of Commerce
Lord, Aeck & Sargent, Inc.
Ambling University Development Group
Heidelberg Technology Park
CRB Engineers & Builders
St. Louis Coalition for Plant & Life Sciences
The University Financing Foundation
Wexford Science & Technology, LLC
Bilbao Technology Park
Point A Consulting, LLC
Smartegies, LLC
Georgia Department of Economic Development
Liverpool Science Park
The University Financing Foundation
Altea Therapeutics Corporation
Fundacion Parque Cientifico de Murcia
Wexford Science & Technology, LLC
HDR CUH2A
Buffalo Niagara Medical Campus
Specialty Operations Solutions
National Institute of Standards and Technology (NIST)
Small Technologies Cluster
Scotish Enterprise Edinburgh and Lothians
KUD International
Richard Wittschiebe Hand Architects
Bioscience Real Estate Insights
CardioMEMS, Inc.
University of Louisville Office of Tech Transfer